Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran

Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran

Objectives: HBV infection is a contagious disease that may transmit vertically from mothers to their neonates or horizontally by blood products and body secretions. Over 50�0of Iranian carriers have contracted the infection perinatally, making this the most likely route of transmission of HBV in Ira...

Full description

Bibliographic Details
Format:	Article
Language:	English
Published:	Oman Medical Specialty Board 2011-11-01
Series:	Oman Medical Journal
Subjects:	children HBsAg positive mothers hepatitis B vaccine hepatitis B immunoglobulin anti-HBc anti-HBs
Online Access:	http://journals.indexcopernicus.com/fulltxt.php?ICID=982288

Similar Items

Seromarkers of Hepatitis B virus in newborns with HBsAg positive mothers
by: Yousef Yahyapour (PhD), et al.
Published: (2009-05-01)

Performance Evaluation of an Improved HBsAg Assay (HBsAg NEXT) for the Detection of HBsAg Levels
by: Ekta Gupta, et al.
Published: (2023-12-01)

HBsAg in Cord Blood Qf Newborns of HBsAg-Positive Mothers
by: Adnan S. Wiharta, et al.
Published: (2018-11-01)

Seroprevalence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001
by: Rosini Nilton, et al.
Published: (2003-01-01)

A comparison on HBsAg and HBsAb prevalence in patients with Down syndrome and other mentally retarded patients living in retarded children institutes in Tehran
by: Sahebjamei M. Associate Professor, et al.
Published: (2003-06-01)

Prediction for HBsAg seroconversion in children with chronic hepatitis B
by: Yan-Wei Zhong, et al.
Published: (2021-12-01)

Accuracy Validation of the Elecsys HBsAg II Quant Assay and Its Utility in Resolving Equivocal Qualitative HBsAg Results
by: Jaehyeon Lee, et al.
Published: (2023-02-01)

Occult HBV Infection in Patients Infected by HIV or HCV: Comparison between HBV-DNA and Two Assays for HBsAg
by: Silvia Meschi, et al.
Published: (2024-03-01)

The effectiveness of hepatitis B vaccine in toddlers based on the five-year period national basic health research (Riskesdas 2007, 2013 and 2018) in Indonesia
by: Christina Safira Whinie Lestari, et al.
Published: (2023-05-01)

Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen
by: Joonhong Park, et al.
Published: (2021-11-01)

Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients
by: Wen-Xin Wang, et al.
Published: (2022-07-01)

Prevalence of HBc-Ab among HBs-Ag negative healthy blood donors in south of Iran
by: Farhad Khorami, et al.
Published: (2013-03-01)

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation
by: Yifei Guo, et al.
Published: (2023-02-01)

Clinical implications of HBsAg quantification in patients with chronic hepatitis B
by: Mauro Viganò, et al.
Published: (2012-01-01)

Seroprevalence of HBsAg, Anti-HBs, anti-HDV and HDVAg in Inonu University Medical Faculty Hospital, 2012 [Inonu Universitesi Tip Fakultesi Hastanesinde, 2012 Yilinda, HBsAg, Anti-HBs, Anti-HDV ve HDVAg Seroprevalansi]
by: Yucel Duman, et al.
Published: (2014-03-01)

Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon
by: Hong Li, et al.
Published: (2022-12-01)

T-Cell Receptor β Chain and B-Cell Receptor Repertoires in Chronic Hepatitis B Patients with Coexisting HBsAg and Anti-HBs
by: Qiao Zhan, et al.
Published: (2022-06-01)

A prospective study of hepatitis B virus markers in patients with chronic HBV infection from Brazilian families of Western and Asian origin
by: F.J. Carrilho, et al.
Published: (2005-09-01)

Occult Hbv Infection in Hbsag Negative and Anti-Hbc Positive Blood Donors.
by: A Shebanizadeh, et al.
Published: (2007-04-01)

Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study
by: Ying-Ming Chiu, et al.
Published: (2017-11-01)

Incidência pós-transfusional do HBsAg em crianças com doenças neoplásicas Post-transfusional incidence of HBsAg in children with neoplastic diseases
by: Maria Zélia Fernandes, et al.
Published: (2009-04-01)

PEMERIKSAAN HEPATITIS B SURFACE ANTIGEN (HBsAg) DAN Anti-HBs PADA IBU HAMIL
by: Herlando Sinaga, et al.
Published: (2018-12-01)

Geographic distribution of HBsAg subtypes in Brazil Distribuição geográfica dos subtipos de antígenos de HBsAg no Brasil
by: Ana Maria Coimbra Gaspar, et al.
Published: (1987-06-01)

Is Quantitative HBsAg Measurement a Reliable Substitute for HBV DNA Quantitation?
by: Mohammad Reza Mahdavi, et al.
Published: (2015-07-01)

Seroprevalences of HBsAg, Anti-HBs, and Anti-HCV in Serum Samples Obtained from Syrian-Origin and Non-Syrian-Origin Patients Admitted to Kahramanmaras Necip Fazil City Hospital in the Last Two Years
by: Esra ÖZKAYA, et al.
Published: (2015-09-01)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
by: Lorenzo Piermatteo, et al.
Published: (2023-12-01)

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers
by: Luisa Roade, et al.
Published: (2023-10-01)

Coexistence of HBsAg/Anti-HBs and HBeAg/Anti-HBe in Sudanese Patients with Chronic Hepatitis B Virus Infection: A Cross-Sectional Study
by: Taqwa Hashim, et al.
Published: (2023-12-01)

Prevalence of Hepatitis B Serum Markers in Young Military Recruits in Greece: A Comparison Study between 2005 and 2019 Cohorts
by: Nikolaos Papadopoulos, et al.
Published: (2021-11-01)

Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection
by: Romina Salpini, et al.
Published: (2020-01-01)

Seroprevalence of hepatitis B surface antigen (HBsAg) in Bo, Sierra Leone, 2012–2013
by: Rashid Ansumana, et al.
Published: (2018-02-01)

Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials
by: Zhang Yu-guo, et al.
Published: (2011-06-01)

Frequency of HBsAg in pregnant women in Gorgan, Iran
by: Cheraghali F (MD), et al.
Published: (2012-01-01)

Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico
by: Arturo Panduro, et al.
Published: (2023-10-01)

Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report
by: Nicholas Brousseau, et al.
Published: (2017-04-01)

Antibody levels in children after 10 years of vaccination against hepatitis B: a brazilian community-based study
by: Glauco Danielle Fagundes, et al.
Published: (2012-04-01)

Molecular Detection of Hepatitis B Virus Among HBsAg Non-Reactive Blood of Donors
by: Habibat Bello, et al.
Published: (2022-12-01)

Molecular Detection of Hepatitis B Virus Among HBsAg Non-Reactive Blood of Donors
by: Habibat Bello, et al.
Published: (2022-12-01)

HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B
by: Pin-Nan Cheng, et al.
Published: (2014-11-01)

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer
by: Benoit Visseaux, et al.
Published: (2024-03-01)